Clinical analysis of prostate cancer in young men under 50 years

Xiangyi Zheng(Tianjin University), Liping Xie(First Affiliated Hospital Zhejiang University), Jin Zhou(First Affiliated Hospital Zhejiang University), Ben Liu(Yichun University), Shuo Wang(Tianjin University of Science and Technology)
Zhonghua miniao waike zazhi
November 15, 2014
10.3760/cma.j.issn.1000-6702.2014.11.011
Cited by 0

Related Papers

The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer
|Molecular Cancer|2020|383
Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis
|World Journal of Surgical Oncology|2019|276
Induction of oligodendrocyte differentiation by Olig2 and Sox10: Evidence for reciprocal interactions and dosage-dependent mechanisms
|Developmental Biology|2006|219
Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels
|Oncotarget|2017|207